Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 11.27
+0.08 (0.71%)
Apr 8, 2026, 3:00 PM CST
SHA:600380 Revenue
In the year 2025, Joincare Pharmaceutical Group Industry had annual revenue of 15.22B CNY, down -2.58%. Joincare Pharmaceutical Group Industry had revenue of 3.74B in the quarter ending December 31, 2025, with 0.46% growth.
Revenue
15.22B
Revenue Growth
-2.58%
P/S Ratio
1.31
Revenue / Employee
1.06M
Employees
14,350
Market Cap
19.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.22B | -403.74M | -2.58% |
| Dec 31, 2024 | 15.62B | -1.03B | -6.17% |
| Dec 31, 2023 | 16.65B | -496.40M | -2.90% |
| Dec 31, 2022 | 17.14B | 1.24B | 7.79% |
| Dec 31, 2021 | 15.90B | 2.38B | 17.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Double-Crane Pharmaceutical | 11.00B |
| Apeloa Pharmaceutical Co.,Ltd | 9.78B |
| Tasly Pharmaceutical Group | 8.24B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Betta Pharmaceuticals | 3.26B |
| Tonghua Dongbao Pharmaceutical | 2.74B |
| Walvax Biotechnology | 2.42B |
| Jilin Aodong Pharmaceutical Group | 2.34B |